COVID–19 and arterial thrombosis: Report of 2 cases

The SARS-CoV-2 infection has been predominately associated with lung disease. However, emerging evidence has associated the COVID-19 infection with a hypercoagulable state. This hypercoagulable state can occur despite the use of anticoagulants and antiplatelets. In fact, it may even be the presentin...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Balraj, Kaur, Parminder, Patel, Prem, Nabati, Camellia, Ayad, Sarah, Shamoon, Fayez, Maroules, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084284/
https://www.ncbi.nlm.nih.gov/pubmed/33968287
http://dx.doi.org/10.1016/j.radcr.2021.04.033
Descripción
Sumario:The SARS-CoV-2 infection has been predominately associated with lung disease. However, emerging evidence has associated the COVID-19 infection with a hypercoagulable state. This hypercoagulable state can occur despite the use of anticoagulants and antiplatelets. In fact, it may even be the presenting symptom of COVID–19 in some patients. Thromboembolism associated with COVID–19 carries a worse prognosis and should be identified as early as possible. Therefore, we report 2 patients with arterial thrombosis in the form of limb ischemia in the setting of COVID-19.

Ejemplares similares